AOD-9604 vs MOTS-c
Compare AOD-9604, MOTS-c: half-life, time to Cmax, dosing interval, published dose ranges and titration — citation-backed, research use only.
| AOD-9604View AOD-9604 → | MOTS-cView MOTS-c → | |
|---|---|---|
| Class | Metabolic | Metabolic |
| Route | Subcutaneous | Subcutaneous |
| Plasma half-life | 1 h | 3 h |
| Time to Cmax | ~30 min | 1 h |
| Typical interval | Once daily | Every 3 days |
| Published dose range | 0.3–0.5 mg | 5–10 mg |
| Titration ladder | No preset ladder | No preset ladder |
| Summary | Hexadecapeptide fragment (177-191) of human growth hormone. Studied for lipolytic effects. | Mitochondrial-derived 16-residue peptide. Studied for metabolic and exercise-mimetic effects. |
Source references
AOD-9604
- Heffernan M et al., Endocrinology 142:5182 (2001)
MOTS-c
- Lee C et al., Cell Metab 21:443 (2015)
For research use only. Not for human consumption. This tracker visualises only the doses you have logged or scheduled — it does not recommend dose sizes, does not suggest what to take, and is not pharmacokinetically calibrated. It is not medical advice and does not diagnose, treat, cure, or prevent any condition. Consult a licensed clinician before making any medical decision.